Skip to main content

Table 20 Antiviral activity of the titled compounds [25]

From: Therapeutic potential of oxadiazole or furadiazole containing compounds

Compound

R1

R2

Curative activity(%)

Protective activity(%)

Inactivation activity(%)

37a

4-F

4-F

43.2 ± 2.1

55.9 ± 1.7

84.4 ± 1.2

37b

4-F

4-Cl

25.9 ± 1.8

52.5 ± 1.5

88.4 ± 0.8

37c

4-F

4-Br

45.6 ± 1.9

67.9 ± 3.9

74.8 ± 1.3

37d

4-F

2-F

31.1 ± 2.3

68.4 ± 3.2

83.4 ± 1.6

37e

4-F

2-Cl

23.7 ± 3.1

56.8 ± 2.6

56.2 ± 1.9

37f

4-F

2,4-Di-Cl

52.9 ± 4.5

65.1 ± 3.2

83.5 ± 2.7

37g

4-F

H

28.2 ± 1.1

52.9 ± 0.7

74.5 ± 0.9

37h

4-F

4-CH3

19.2 ± 0.9

60.5 ± 1.1

61.3 ± 0.8

37i

4-F

4-OCH3

27.5 ± 2.1

50.0 ± 1.5

61.4 ± 1.0

37j

4-F

2-CF3

28.3 ± 2.3

47.5 ± 2.4

60.2 ± 1.7

38a

H

4-F

45.8 ± 1.8

61.5 ± 2.9

69.1 ± 1.2

38b

H

4-Cl

44.1 ± 2.5

55.7 ± 1.6

59.4 ± 2.5

38c

H

4-Br

47.2 ± 3.6

53.8 ± 3.9

83.1 ± 2.4

38d

H

2-F

38.1 ± 2.6

66.3 ± 1.9

70.1 ± 2.0

38e

H

2-Cl

41.1 ± 4.2

61.5 ± 3.1

75.6 ± 2.1

38f

H

2,4-Di-Cl

49.8 ± 3.9

69.2 ± 2.1

90.4 ± 2.8

38g

H

H

20.9 ± 2.1

66.7 ± 2.8

78.0 ± 2.5

38h

H

4-CH3

48.1 ± 3.6

57.5 ± 2.7

72.7 ± 3.3

38i

H

4-OCH3

40.6 ± 3.2

58.4 ± 3.8

79.3 ± 4.1

38j

H

2-CF3

35.5 ± 1.7

50.5 ± 1.9

56.8 ± 2.1

39a

4-OCH3

4-F

20.8 ± 1.2

44.0 ± 0.9

83.0 ± 1.1

39b

4- OCH3

4-Cl

18.4 ± 0.9

34.4 ± 1.1

87.1 ± 1.8

39c

4- OCH3

4-Br

34.8 ± 2.1

41.1 ± 3.6

82.3 ± 5.1

39d

4- OCH3

2-F

25.4 ± 1.7

35.8 ± 1.4

81.3 ± 2.1

39e

4- OCH3

2-Cl

43.5 ± 2.2

46.1 ± 2.6

77.7 ± 2.0

39f

4- OCH3

2,4-Di-Cl

43.9 ± 2.4

49.6 ± 1.8

85.6 ± 1.9

39g

4- OCH3

H

37.8 ± 1.6

42.5 ± 2.0

78.8 ± 2.1

39h

4- OCH3

4-CH3

26.5 ± 1.2

42.1 ± 2.1

86.3 ± 5.4

39i

4- OCH3

4-OCH3

35.1 ± 1.5

41.5 ± 1.8

81.5 ± 2.6

39j

4- OCH3

2-CF3

30.5 ± 2.1

49.3 ± 2.3

77.9 ± 4.5

38k

H

2,4-Di-F

55.4 ± 2.8

71.3 ± 1.9

85.2 ± 4.0

Ribavirin

  

37.9 ± 1.9

51.8 ± 2.3

72.9 ± 2.4